Quest Diagnostics beats Q1 profit estimate, raises FY forecast

Quest Diagnostics

21/04/2026 11:55

Overview

U.S. diagnostic services provider's Q1 revenue grew 9.2% yr/yr, beating analyst expectations

Adjusted diluted EPS for Q1 rose 13.1%, beating analyst expectations

Company raised full-year 2026 revenue and EPS guidance after robust Q1 performance

Outlook

Quest Diagnostics raises 2026 net revenue guidance to $11.78 bln-$11.90 bln from $11.70 bln-$11.82 bln

Company now expects 2026 reported diluted EPS of $9.58-$9.78, up from $9.45-$9.65

Company sees 2026 adjusted diluted EPS of $10.63-$10.83, up from $10.50-$10.70

Result Drivers

ORGANIC VOLUME GROWTH - Nearly all revenue growth in Q1 was organic, driven by increased requisition volume

CONSUMER CHANNEL - Revenue grew robustly across the consumer channel through questhealth.com and collaborations with consumer health companies

ADVANCED DIAGNOSTICS - Double-digit revenue growth in Advanced Diagnostics, including Alzheimer's blood tests and advanced cardiometabolic and endocrine disease areas

Company press release: ID:nPn2hTtN7a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$2.90 bln
$2.83 bln (14 Analysts)
Q1 Adjusted EPS
Beat
$2.50
$2.35 (16 Analysts)
Q1 EPS
$2.24
Q1 Net Income
$252 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Quest Diagnostics Inc is $220.00, about 12.1% above its April 20 closing price of $196.31

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 17 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)